NUZ 5.26% 20.0¢ neurizon therapeutics limited

Covi-Pantel . NZ Trader Release, page-1081

  1. 2,437 Posts.
    lightbulb Created with Sketch. 1515
    I'm frustrated as anybody but I take all their timeline announcements with a good dose of salt. Unfortunately working on the very edge of scientific knowledge is very hard and very unpredictable. This is why risk-reward in this game is high. SURPRISE ! While we're waiting for the covid trial results from the Netherlands, glad to see the phase II (b) dog cancer trial off and running, hopefully this time they can get suitable candidates faster and see if they can 1. solve the appetite issue which would mean a much larger usage of the drug for both dogs and humans than otherwise would be the case (and therefore support a much higher valuation than otherwise) and 2. for bonus points make the drug even more effective than was ever hoped for before the last trial.

    Be sensible and GLTA
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.010(5.26%)
Mkt cap ! $98.34M
Open High Low Value Volume
20.0¢ 20.5¢ 19.5¢ $84.52K 421.2K

Buyers (Bids)

No. Vol. Price($)
2 49269 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 18063 2
View Market Depth
Last trade - 14.47pm 15/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.